| LIGAND PHARMACEUTICALS INC | LGND | Octavio EspinozaCFODERIV | Aug 12 | MPLAN | 2,074 | $0.00 | —? |
| LIGAND PHARMACEUTICALS INC | LGND | Octavio EspinozaCFODERIV | Aug 12 | MPLAN | 3,348 | $0.00 | —? |
| LIGAND PHARMACEUTICALS INC | LGND | Octavio EspinozaCFODERIV | Aug 12 | MPLAN | 16,179 | $0.00 | —? |
| LIGAND PHARMACEUTICALS INC | LGND | Octavio EspinozaCFODERIV | Aug 12 | MPLAN | 7,171 | $0.00 | —? |
| LIGAND PHARMACEUTICALS INC | LGND | Octavio EspinozaCFODERIV | Aug 12 | MPLAN | 2,869 | $0.00 | —? |
| LIGAND PHARMACEUTICALS INC | LGND | Octavio EspinozaCFO | Aug 12 | SPLAN | 31,641 | $292.07 | $9.2M |
| LIGAND PHARMACEUTICALS INC | LGND | Octavio EspinozaCFO | Aug 12 | MPLAN | 3,348 | $68.74 | $230K |
| LIGAND PHARMACEUTICALS INC | LGND | Octavio EspinozaCFO | Aug 12 | MPLAN | 7,171 | $57.22 | $410K |
| LIGAND PHARMACEUTICALS INC | LGND | Octavio EspinozaCFO | Aug 12 | MPLAN | 2,869 | $55.75 | $160K |
| LIGAND PHARMACEUTICALS INC | LGND | Octavio EspinozaCFO | Aug 12 | MPLAN | 2,074 | $70.04 | $145K |
| LIGAND PHARMACEUTICALS INC | LGND | Octavio EspinozaCFO | Aug 12 | MPLAN | 16,179 | $52.84 | $855K |
| LIGAND PHARMACEUTICALS INC | LGND | Octavio EspinozaCFO | Jun 30 | J | 17 | $160.71 | $3K |
| LIGAND PHARMACEUTICALS INC | LGND | Octavio EspinozaCFODERIV | May 27 | M | 764 | $0.00 | —? |
| LIGAND PHARMACEUTICALS INC | LGND | Octavio EspinozaCFODERIV | May 27 | M | 972 | $0.00 | —? |
| LIGAND PHARMACEUTICALS INC | LGND | Octavio EspinozaCFO | May 27 | M | 972 | $52.84 | $51K |
| LIGAND PHARMACEUTICALS INC | LGND | Octavio EspinozaCFO | May 27 | M | 764 | $63.62 | $49K |
| LIGAND PHARMACEUTICALS INC | LGND | Octavio EspinozaCFODERIV | Mar 2 | A | 23,527 | $0.00 | —? |
| LIGAND PHARMACEUTICALS INC | LGND | Octavio EspinozaCFO | Mar 2 | A | 4,933 | $0.00 | — |
| LIGAND PHARMACEUTICALS INC | LGND | Octavio EspinozaCFODERIV | Mar 11 | MPLAN | 2,405 | $0.00 | —? |
| LIGAND PHARMACEUTICALS INC | LGND | Octavio EspinozaCFO | Mar 11 | SPLAN | 3,057 | $225.00 | $688K |
| LIGAND PHARMACEUTICALS INC | LGND | Octavio EspinozaCFO | Mar 11 | MPLAN | 2,405 | $92.65 | $223K |
| LIGAND PHARMACEUTICALS INC | LGND | Octavio EspinozaCFODERIV | Mar 4 | MPLAN | 466 | $0.00 | —? |
| LIGAND PHARMACEUTICALS INC | LGND | Octavio EspinozaCFODERIV | Mar 4 | MPLAN | 1,607 | $0.00 | —? |
| LIGAND PHARMACEUTICALS INC | LGND | Octavio EspinozaCFO | Mar 4 | SPLAN | 3,413 | $208.80 | $713K |
| LIGAND PHARMACEUTICALS INC | LGND | Octavio EspinozaCFO | Mar 4 | SPLAN | 2,457 | $207.91 | $511K |
| LIGAND PHARMACEUTICALS INC | LGND | Octavio EspinozaCFO | Mar 4 | SPLAN | 1,588 | $206.89 | $329K |
| LIGAND PHARMACEUTICALS INC | LGND | Octavio EspinozaCFO | Mar 4 | SPLAN | 1,457 | $205.79 | $300K |
| LIGAND PHARMACEUTICALS INC | LGND | Octavio EspinozaCFO | Mar 4 | SPLAN | 743 | $204.74 | $152K |
| LIGAND PHARMACEUTICALS INC | LGND | Octavio EspinozaCFO | Mar 4 | SPLAN | 668 | $203.63 | $136K |
| LIGAND PHARMACEUTICALS INC | LGND | Octavio EspinozaCFO | Mar 4 | SPLAN | 697 | $202.79 | $141K |
| LIGAND PHARMACEUTICALS INC | LGND | Octavio EspinozaCFO | Mar 4 | SPLAN | 950 | $201.73 | $192K |
| LIGAND PHARMACEUTICALS INC | LGND | Octavio EspinozaCFO | Mar 4 | SPLAN | 698 | $201.09 | $140K |
| LIGAND PHARMACEUTICALS INC | LGND | Octavio EspinozaCFO | Mar 4 | SPLAN | 53 | $200.08 | $11K |
| LIGAND PHARMACEUTICALS INC | LGND | Octavio EspinozaCFO | Mar 4 | SPLAN | 699 | $198.71 | $139K |
| LIGAND PHARMACEUTICALS INC | LGND | Octavio EspinozaCFO | Mar 4 | MPLAN | 466 | $80.72 | $38K |
| LIGAND PHARMACEUTICALS INC | LGND | Octavio EspinozaCFO | Mar 4 | MPLAN | 1,607 | $58.49 | $94K |
| LIGAND PHARMACEUTICALS INC | LGND | Octavio EspinozaCFO | Feb 15 | F | 1,270 | $183.83 | $233K |
| LIGAND PHARMACEUTICALS INC | LGND | Octavio EspinozaCFO | Feb 15 | F | 1,223 | $183.83 | $225K |
| LIGAND PHARMACEUTICALS INC | LGND | Octavio EspinozaCFO | Feb 15 | F | 1,026 | $183.83 | $189K |
| LIGAND PHARMACEUTICALS INC | LGND | Octavio EspinozaCFO | Feb 14 | F | 4,483 | $183.83 | $824K |
| LIGAND PHARMACEUTICALS INC | LGND | Octavio EspinozaCFO | Feb 14 | A | 8,810 | $0.00 | — |
| LIGAND PHARMACEUTICALS INC | LGND | Octavio EspinozaCFO | Feb 14 | F | 3,761 | $183.83 | $691K |
| LIGAND PHARMACEUTICALS INC | LGND | Octavio EspinozaCFO | Feb 14 | A | 7,390 | $0.00 | — |
| LIGAND PHARMACEUTICALS INC | LGND | Octavio EspinozaCFO | Dec 31 | J | 8 | $95.68 | $765 |